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To the editor
Undernutrition is common among HIV patients starting antiretroviral therapy (ART) in 
Africa (1), but data on determinants of long-term health including hypertension among these 
patients are lacking. As part of a cross-sectional follow-up study to investigate predictors of 
dysglycaemia in HIV patients who were recruited in the Nutritional Support for African 
Patients Starting Antiretroviral Therapy (NUSTART) trial 2–3 earlier(2, 3), we determined 
prevalence and correlates of elevated blood pressure among patients who started ART when 
undernourished in Tanzania.
Data on demography, non-communicable diseases risk factors (smoking, alcohol drinking, 
physical activity, and vegetable and fruit intake), anthropometry, body composition, ART 
use history and adherence, tuberculosis (TB) treatment history since NUSTART enrolment, 
C-Reactive Protein, CD4 count, and pre-diabetes and diabetes were collected as described 
previously(3). TB and HIV treatment were confirmed with treatment cards or clinics. Blood 
pressure was assessed using a digital machine (Omron Healthcare, Binh Duong, Vietnam). 
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Prehypertension was defined as systolic blood pressure of 120 to 139 mm Hg and/or 
diastolic blood pressure of 80 to 89 mm Hg whereas hypertension was defined as systolic 
blood pressure of ≥140 mmHg and/or diastolic blood pressure of ≥90 mmHg(4). Both 
prehypertension and hypertension were considered elevated blood pressure. The predictors 
of elevated blood pressure ) were determined using logistic regression; age, sex and 
covariates with P≤0.10 in the univariate analysis were included in the multivariable models.
The background characteristics of 273 patients followed-up have been reported(3). Briefly, 
the mean age was 41.5(9.8) years and 178 (65.2%) were females; 11 (4%) were current 
smokers, 31 (11.4%) were current alcohol drinkers, 12 (4.2%) were either overweight or 
obese, and 77 (28.2%) had received TB treatment since NUSTART enrolment 2–3 years 
previously. Five (1.8 %) had hypertension and 51 (18.7%) had either prehypertension or 
hypertensionwhich is elevated blood pressure in excess of 120/80mmHg. In multivariable 
logistic regression, age (OR 1.05 (1.0, 1.1) increased the risk of elevated blood pressure, but 
receiving TB treatment reduced the risk (OR: 0.25 (0.1, 0.7) of elevated blood pressure 
(Table 1). Other covariates were not significant predictors.
In this analysis, we report a very high prevalence of elevated blood pressure. Although the 
prevalence of frank hypertension was low, the high prevalence of prehypertension (about 
16.9%) is of concern, since similar to hypertension, prehypertension is associated with an 
increased risk of cardiovascular disease among the general population(5) and possibly 
among HIV-infected patients.
The lack of association with traditional modifiable risk factors for non-communicable 
diseases suggests that non-traditional risk factors, in addition to age, may be major 
contributors to the evolution of elevated blood pressure in this population. Although not 
receiving TB treatment could be one of those determinants, the mechanism underlying this 
association is difficult to explain. We suggest two possible explanations. First, those not on 
TB treatment could have latent or undiagnosed subclinical TB which could have 
compromised the integrity of blood vessels due cell-mediated immune response and chronic 
inflammation (6). The damaged vessels would probably increase their risk of elevated blood 
pressure. The existence of widespread latent or subclinical TB in the NUSTART population 
is likely, based on our previous observation that TB treatment was associated with decreased 
mortality in these patients (2). Second, mortality in this cohort, during NUSTART trial and 
2–3 years follow-up, was high (approximately 40%; unpublished data). Given the many 
competing factors leading to death in this initially seriously ill population, it is possible that 
the association between being on TB treatment at the start of ART and elevated blood 
pressure after 2–3 years on ART is spurious.
Further research is needed to investigate TB and other potential determinants of elevated 
blood pressure to help control this condition among patients starting ART when 
malnourished.
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